Investors of Unicycive Therapeutics, Inc. should reach out to The Gross Law Firm prior to October 14, 2025, to explore potential legal actions regarding their shares - UNCY
News Article: Gross Law Firm Issues Notice to Unicycive Therapeutics Shareholders
The Gross Law Firm has issued a notice to shareholders of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) regarding a potential class action lawsuit. The notice, available at https://securitiesclasslaw.com/securities/unicycive-therapeutics-inc-loss-submission-form/?id=167832&from=3, is related to shares of Unicycive Therapeutics purchased during the class period from March 29, 2024 to June 27, 2025.
The complaint, filed by The Gross Law Firm, alleges that defendants' public statements during the class period were materially false and misleading. Specifically, it suggests that Unicycive overstated its readiness and ability to satisfy the FDA's manufacturing compliance requirements, and that the oxylanthanum carbonate new drug application's regulatory prospects were overstated during the same period.
Shareholders who fit the class period criteria are encouraged to contact The Gross Law Firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. The deadline to seek to be a lead plaintiff in this class action is October 14, 2025.
The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors who have suffered due to deceit, fraud, and illegal business practices. The firm is committed to ensuring companies adhere to responsible business practices and engage in good corporate citizenship.
Registering as a shareholder who purchased shares of UNCY during the specified timeframe will enroll you in a portfolio monitoring software for case updates. It's important to note that the press release does not specify the names of the individual defendants accused of making materially false or incomplete statements during the class period for Unicycive Therapeutics, Inc.
The Gross Law Firm seeks recovery on behalf of investors who incurred losses due to false and/or misleading statements or the omission of material information by a company leading to artificial inflation of the company's stock.
Attorney advertising. Prior results do not guarantee similar outcomes. For more information or to discuss your potential role in the class action, please visit the link provided or contact The Gross Law Firm using the contact information below.
Contact Information for The Gross Law Firm: Address: 2060 Stevens Creek Blvd., Suite 210, San Jose, California 95128 Email: [email protected] Phone: (888) 296-2555
The Gross Law Firm represents investors, consumers, and whistleblowers nationwide.
